deferasirox has been researched along with Hyperammonemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Guerriero, R; Guilliams, KP; Hulbert, ML; Shinawi, MS; Stoll, JM; Towerman, AS; Willis, DN | 1 |
| Bolaman, AZ; Turgutkaya, A; Yavaşoğlu, İ | 1 |
| Falvella, FS; Goffredo, BM; Marano, M; Martinelli, D | 1 |
3 other study(ies) available for deferasirox and Hyperammonemia
| Article | Year |
|---|---|
Hyperammonemia and acute liver failure associated with deferasirox in two adolescents with sickle cell disease.
Topics: Adolescent; Anemia, Sickle Cell; Benzoates; Deferasirox; Humans; Hyperammonemia; Iron Chelating Agents; Liver Failure, Acute | 2023 |
Deferasirox-Induced Hyperammonemia in an Adult Patient After Allogeneic Stem Cell Transplantation.
Topics: Adult; Deferasirox; Hematopoietic Stem Cell Transplantation; Humans; Hyperammonemia; Triazoles | 2022 |
Acute hyperammonemia in children under deferasirox treatment: cutting the Gordian knot.
Topics: Acute Disease; Adolescent; Age Factors; Ammonia; Biomarkers; Child, Preschool; Deferasirox; Female; Humans; Hyperammonemia; Iron Chelating Agents; Male; Risk Factors | 2019 |